$EBZT
Everything Blockchain, Inc.

2023 Q2 Form 10-Q Financial Statement

#000147793223004564 Filed on June 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $262.0K $152.0K
YoY Change 2.75% -93.87%
Cost Of Revenue $52.00K -$6.000K
YoY Change 246.67% -102.6%
Gross Profit $210.0K $158.0K
YoY Change -12.5% -92.98%
Gross Profit Margin 80.15% 103.95%
Selling, General & Admin $1.230M $1.582M
YoY Change 12.53% -62.18%
% of Gross Profit 585.71% 1001.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $59.00K $178.0K
YoY Change 18.0% 439.39%
% of Gross Profit 28.1% 112.66%
Operating Expenses $2.005M $1.620M
YoY Change 3.03% -62.14%
Operating Profit -$1.795M -$1.462M
YoY Change 5.22% -27.94%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$17.00K -$17.00K
YoY Change -89.38% -100.33%
Pretax Income -$1.812M -$2.933M
YoY Change -2.89% -193.05%
Income Tax $7.000K $1.125M
% Of Pretax Income
Net Earnings -$1.819M -$4.058M
YoY Change 25.1% -275.14%
Net Earnings / Revenue -694.27% -2669.74%
Basic Earnings Per Share -$0.18
Diluted Earnings Per Share -$0.18 -$0.41
COMMON SHARES
Basic Shares Outstanding 9.923M shares
Diluted Shares Outstanding 9.923B shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.000K $824.0K
YoY Change -99.65% -22.41%
Cash & Equivalents $6.000K $824.0K
Short-Term Investments
Other Short-Term Assets $173.0K $127.0K
YoY Change 226.42% 252.78%
Inventory $74.00K $64.00K
Prepaid Expenses $2.541M $2.663M
Receivables $66.00K $89.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.864M $3.771M
YoY Change -62.68% -47.91%
LONG-TERM ASSETS
Property, Plant & Equipment $654.0K $660.0K
YoY Change -32.65% -34.07%
Goodwill $16.50M $16.50M
YoY Change -7.4% -7.4%
Intangibles $4.270M
YoY Change
Long-Term Investments
YoY Change
Other Assets $463.0K $463.0K
YoY Change 0.0% 0.0%
Total Long-Term Assets $22.06M $21.90M
YoY Change -2.71% -2.27%
TOTAL ASSETS
Total Short-Term Assets $2.864M $3.771M
Total Long-Term Assets $22.06M $21.90M
Total Assets $24.92M $25.67M
YoY Change -17.88% -13.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.651M $1.305M
YoY Change 972.08% 747.4%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $479.0K $474.0K
YoY Change 69.86% 68.09%
Total Short-Term Liabilities $2.412M $2.071M
YoY Change 41.22% 57.85%
LONG-TERM LIABILITIES
Long-Term Debt $40.00K $47.00K
YoY Change -84.79% -82.66%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $40.00K $47.00K
YoY Change -91.42% -94.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.412M $2.071M
Total Long-Term Liabilities $40.00K $47.00K
Total Liabilities $2.452M $2.118M
YoY Change 12.79% -3.73%
SHAREHOLDERS EQUITY
Retained Earnings -$62.35M -$60.54M
YoY Change 18.67% 18.48%
Common Stock $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.691M $1.691M
YoY Change 5.75%
Treasury Stock Shares
Shareholders Equity $22.47M $23.55M
YoY Change
Total Liabilities & Shareholders Equity $24.92M $25.67M
YoY Change -17.88% -13.42%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.819M -$4.058M
YoY Change 25.1% -275.14%
Depreciation, Depletion And Amortization $59.00K $178.0K
YoY Change 18.0% 439.39%
Cash From Operating Activities -$688.0K -$2.793M
YoY Change 28.36% -276.77%
INVESTING ACTIVITIES
Capital Expenditures $222.0K $1.221M
YoY Change -169.59% -190.51%
Acquisitions
YoY Change
Other Investing Activities $758.0K
YoY Change -207.06%
Cash From Investing Activities -$222.0K -$463.0K
YoY Change -30.41% -77.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $92.00K 3.018M
YoY Change -93.83% -43214.29%
NET CHANGE
Cash From Operating Activities -$688.0K -2.793M
Cash From Investing Activities -$222.0K -463.0K
Cash From Financing Activities $92.00K 3.018M
Net Change In Cash -$818.0K -238.0K
YoY Change -228.41% -50.83%
FREE CASH FLOW
Cash From Operating Activities -$688.0K -$2.793M
Capital Expenditures $222.0K $1.221M
Free Cash Flow -$910.0K -$4.014M
YoY Change 319.35% -237.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
52000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
210000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
240000 usd
CY2023Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
13000 usd
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001730869
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9949966 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
000-56142
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Everything Blockchain, Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1091922
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
12574 Flagler Center Blvd
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 101
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Jacksonville
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32258
CY2023Q2 dei City Area Code
CityAreaCode
904
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
454-2111
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1093000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
716000 usd
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9923304 shares
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
463000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
463000 usd
CY2023Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
32000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
47000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
40000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
47000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9949966 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9923304 shares
CY2023Q2 us-gaap Revenues
Revenues
262000 usd
CY2022Q2 us-gaap Revenues
Revenues
255000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
15000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1230000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
803000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
59000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
50000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2005000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1946000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1795000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1706000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-160000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1812000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1866000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-412000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1819000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1454000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9923304000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8665836000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9923304000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8665836000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
27445000 usd
CY2022Q2 ebi Issuance Of Series C Preferred Amount
IssuanceOfSeriesCPreferredAmount
1000000 usd
CY2022Q2 ebi Stockissued During Period Value Issued For Warrants Exercises
StockissuedDuringPeriodValueIssuedForWarrantsExercises
500000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
685000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1454000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
28176000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23550000 usd
CY2023Q2 ebi Stockissued During Period Value Issued For Warrants Exercises
StockissuedDuringPeriodValueIssuedForWarrantsExercises
100000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
641000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1819000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
22472000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1819000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1454000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
716000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
803000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-415000 usd
CY2023Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
CY2022Q2 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
26000 usd
CY2023Q2 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
0 usd
CY2022Q2 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
147000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
59000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
50000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10000 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-47000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-51000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
46000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
17000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
19000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-6000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
352000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
250000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-29000 usd
CY2022Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
152000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-688000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-536000 usd
CY2023Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
222000 usd
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
319000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-222000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-319000 usd
CY2023Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
8000 usd
CY2022Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
8000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1000000 usd
CY2023Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
100000 usd
CY2022Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
500000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1492000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-818000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
637000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
824000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1062000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1699000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
17000 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
13000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;font-family:times new roman;margin:0px">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The most significant estimates and judgments relate to revenue recognition; sales returns and other allowances; allowance for doubtful accounts; valuation of inventory; valuation of long-lived assets and finite-lived intangible assets; recoverability of goodwill; acquisition method of accounting; contingencies; and income taxes.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On a regular basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments which potentially subject the Company to a concentration of credit risk consist principally of temporary cash investments and accounts receivable. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Concentrations of credit risk with respect to trade receivables and commodities are limited due to the Company’s diverse group of customers. The Company establishes an allowance for doubtful accounts when events and circumstances regarding the collectability of its receivables or the selling of its commodities warrant based upon factors such as the credit risk of specific customers, historical trends, other information, and past bad debt history. The outstanding balances are stated net of an allowance for doubtful accounts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our cash balances are maintained in accounts held by major banks and financial institutions located in the United States. The Company may occasionally maintain amounts on deposit with a financial institution that are in excess of the federally insured limit of $250,000. The risk is managed by maintaining all deposits in high-quality financial institutions. The Company had $0 and $0.4 million in excess of federally insured limits on April 30, 2023 and  January 31, 2023, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our cryptocurrency balances are maintained in accounts held by institutions located in and outside the United States. The Company maintains amounts on deposit that often exceed coverage from third party insured limit of up to $1,000,000. The risk is managed by maintaining multiple accounts with various accounts held in a cold storage wallet. The Company had $4,000 in excess of amounts protected by insurance. </p>
CY2023Q2 ebi Federally Insured Limit
FederallyInsuredLimit
250000 usd
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
400000 usd
CY2023Q2 us-gaap Deposits
Deposits
1000000 usd
CY2023Q2 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
4000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4534000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
95 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4439000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4333000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
63 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4270000 usd
CY2023Q2 ebi Warrants Outstanding Shares Ending
WarrantsOutstandingSharesEnding
3356000 shares
CY2023Q2 ebi Warrants Outstanding Weighted Average Conversion Price Ending
WarrantsOutstandingWeightedAverageConversionPriceEnding
3.60
CY2023Q2 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
250000 shares
CY2023Q2 ebi Fair Market Value
FairMarketValue
4000 usd
CY2023Q1 ebi Fair Market Value
FairMarketValue
4000 usd
CY2023Q2 ebi Other Income Fair Market Value Adjustments
OtherIncomeFairMarketValueAdjustments
100000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
857000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
835000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
203000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
175000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
654000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
660000 usd
CY2023Q2 us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
500000 usd
CY2023Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.063 pure
CY2023Q2 ebi Debt Maturity Range
DebtMaturityRange
from 2023 through 2026
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26662 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9949966 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9923304 shares
CY2023Q2 ebi Warrants Outstanding Shares Beginning
WarrantsOutstandingSharesBeginning
3356000 shares
CY2023Q2 ebi Warrants Outstanding Weighted Average Conversion Price Beginning
WarrantsOutstandingWeightedAverageConversionPriceBeginning
3.60
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.22 pure
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1819000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1454000 usd
CY2023Q2 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
9923 shares
CY2022Q2 us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
8666 shares
CY2023Q2 ebi Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
9923 shares
CY2022Q2 ebi Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
8666 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17

Files In Submission

Name View Source Status
0001477932-23-004564-index-headers.html Edgar Link pending
0001477932-23-004564-index.html Edgar Link pending
0001477932-23-004564.txt Edgar Link pending
0001477932-23-004564-xbrl.zip Edgar Link pending
ebi-20230430.xsd Edgar Link pending
ebi_10q.htm Edgar Link pending
ebi_ex31.htm Edgar Link pending
ebi_ex311.htm Edgar Link pending
ebi_ex312.htm Edgar Link pending
ebi_ex32.htm Edgar Link pending
ebi_ex321.htm Edgar Link pending
ebi-20230430_cal.xml Edgar Link unprocessable
ebi-20230430_def.xml Edgar Link unprocessable
ebi-20230430_lab.xml Edgar Link unprocessable
ebi-20230430_pre.xml Edgar Link unprocessable
ebi_10q_htm.xml Edgar Link completed
ebi_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable